The Oxford-Harrington Rare Disease Centre, a partnership between the University of Oxford, U.K. and Harrington Discovery Institute at University Hospitals, Cleveland, Ohio, is seeking innovative projects for its 2025 Rare Disease Scholar Award, which advances promising discoveries from academic labs into clinical practice. In addition to grant funding, the award includes drug and business development support from pharma-experienced industry leaders.
The OHC’s 2025 Rare Disease Scholar Award seeks novel approaches to treat rare diseases, with a focus on neurological disorders, developmental and metabolic disorders, and rare cancers. Applications directed to other rare, genetic indications with a high unmet need are also of interest. Any therapeutic modality will be considered. Intellectual property rights are retained by the award recipient or their institution.
Submission deadline: March 10, 2025, 11:59 PM ET